352 related articles for article (PubMed ID: 28636791)
1. Isotretinoin and lymecycline treatments modify the skin microbiota in acne.
Kelhälä HL; Aho VTE; Fyhrquist N; Pereira PAB; Kubin ME; Paulin L; Palatsi R; Auvinen P; Tasanen K; Lauerma A
Exp Dermatol; 2018 Jan; 27(1):30-36. PubMed ID: 28636791
[TBL] [Abstract][Full Text] [Related]
2. Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics.
Chien AL; Tsai J; Leung S; Mongodin EF; Nelson AM; Kang S; Garza LA
JAMA Dermatol; 2019 Apr; 155(4):425-434. PubMed ID: 30758497
[TBL] [Abstract][Full Text] [Related]
3. Skin microbiome and acne vulgaris: Staphylococcus, a new actor in acne.
Dreno B; Martin R; Moyal D; Henley JB; Khammari A; Seité S
Exp Dermatol; 2017 Sep; 26(9):798-803. PubMed ID: 28094874
[TBL] [Abstract][Full Text] [Related]
4. The microbiome in preadolescent acne: Assessment and prospective analysis of the influence of benzoyl peroxide.
Ahluwalia J; Borok J; Haddock ES; Ahluwalia RS; Schwartz EW; Hosseini D; Amini S; Eichenfield LF
Pediatr Dermatol; 2019 Mar; 36(2):200-206. PubMed ID: 30656737
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne.
Coates P; Vyakrnam S; Ravenscroft JC; Stables GI; Cunliffe WJ; Leyden JJ; Johnson J; Eady EA; Cove JH
Br J Dermatol; 2005 Dec; 153(6):1126-36. PubMed ID: 16307647
[TBL] [Abstract][Full Text] [Related]
6. Lymecycline and minocycline in inflammatory acne: a randomized, double-blind intent-to-treat study on clinical and in vivo antibacterial efficacy.
Piérard-Franchimont C; Goffin V; Arrese JE; Martalo O; Braham C; Slachmuylders P; Piérard GE
Skin Pharmacol Appl Skin Physiol; 2002; 15(2):112-9. PubMed ID: 11867968
[TBL] [Abstract][Full Text] [Related]
7. Skin Ecology during Sebaceous Drought-How Skin Microbes Respond to Isotretinoin.
McCoy WH; Otchere E; Rosa BA; Martin J; Mann CM; Mitreva M
J Invest Dermatol; 2019 Mar; 139(3):732-735. PubMed ID: 30579608
[No Abstract] [Full Text] [Related]
8. Isotretinoin therapy changes the expression of antimicrobial peptides in acne vulgaris.
Borovaya A; Dombrowski Y; Zwicker S; Olisova O; Ruzicka T; Wolf R; Schauber J; Sárdy M
Arch Dermatol Res; 2014 Oct; 306(8):689-700. PubMed ID: 24916439
[TBL] [Abstract][Full Text] [Related]
9. Treatment of acne patients with isotretinoin increases β-diversity of a putative health-associated strain of Cutibacterium acnes within the follicular microbiome of responders.
McDowell A; Brüggemann H; Layton AM
Exp Dermatol; 2024 Jan; 33(1):e14967. PubMed ID: 37891715
[No Abstract] [Full Text] [Related]
10. In vivo porphyrin production by P. acnes in untreated acne patients and its modulation by acne treatment.
Borelli C; Merk K; Schaller M; Jacob K; Vogeser M; Weindl G; Berger U; Plewig G
Acta Derm Venereol; 2006; 86(4):316-9. PubMed ID: 16874416
[TBL] [Abstract][Full Text] [Related]
11. Characterization and Analysis of the Skin Microbiota in Acne: Impact of Systemic Antibiotics.
Park SY; Kim HS; Lee SH; Kim S
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936262
[TBL] [Abstract][Full Text] [Related]
12. Treatment response to isotretinoin correlates with specific shifts in Cutibacterium acnes strain composition within the follicular microbiome.
Nolan ZT; Banerjee K; Cong Z; Gettle SL; Longenecker AL; Kawasawa YI; Zaenglein AL; Thiboutot DM; Agak GW; Zhan X; Nelson AM
Exp Dermatol; 2023 Jul; 32(7):955-964. PubMed ID: 36999947
[TBL] [Abstract][Full Text] [Related]
13. Emerging drugs for acne.
James KA; Burkhart CN; Morrell DS
Expert Opin Emerg Drugs; 2009 Dec; 14(4):649-59. PubMed ID: 19772370
[TBL] [Abstract][Full Text] [Related]
14. Microorganisms inhabiting follicular contents of facial acne are not only Propionibacterium but also Malassezia spp.
Akaza N; Akamatsu H; Numata S; Yamada S; Yagami A; Nakata S; Matsunaga K
J Dermatol; 2016 Aug; 43(8):906-11. PubMed ID: 26705192
[TBL] [Abstract][Full Text] [Related]
15. Analysis of facial skin-resident microbiota in Japanese acne patients.
Numata S; Akamatsu H; Akaza N; Yagami A; Nakata S; Matsunaga K
Dermatology; 2014; 228(1):86-92. PubMed ID: 24356463
[TBL] [Abstract][Full Text] [Related]
16. Decrease in Diversity of Propionibacterium acnes Phylotypes in Patients with Severe Acne on the Back.
Dagnelie MA; Corvec S; Saint-Jean M; Bourdès V; Nguyen JM; Khammari A; Dréno B
Acta Derm Venereol; 2018 Feb; 98(2):262-267. PubMed ID: 29136261
[TBL] [Abstract][Full Text] [Related]
17. Qualitative and quantitative changes in cutaneous bacteria associated with systemic isotretinoin therapy for acne conglobata.
Leyden JJ; McGinley KJ; Foglia AN
J Invest Dermatol; 1986 Apr; 86(4):390-3. PubMed ID: 2943823
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes.
Sadhasivam S; Sinha M; Saini S; Kaur SP; Gupta T; Sengupta S; Ghosh S; Sardana K
Dermatol Ther; 2016 Nov; 29(6):451-454. PubMed ID: 27424878
[TBL] [Abstract][Full Text] [Related]
19. Multicenter cross-sectional observational study of antibiotic resistance and the genotypes of Propionibacterium acnes isolated from Chinese patients with acne vulgaris.
Fan Y; Hao F; Wang W; Lu Y; He L; Wang G; Chen W
J Dermatol; 2016 Apr; 43(4):406-13. PubMed ID: 26508505
[TBL] [Abstract][Full Text] [Related]
20. Does oral isotretinoin prevent Propionibacterium acnes resistance?
Coates P; Adams CA; Cunliffe WJ; McGinley KT; Eady EA; Leyden JJ; Ravenscroft J; Vyakrnam S; Vowels B
Dermatology; 1997; 195 Suppl 1():4-9; discussion 38-40. PubMed ID: 9310739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
